Publications for Robyn Saw
Publications for Robyn Saw
Australian Family Physician, 44(1), 43-45.
2016
Read, R., Haydu, L., Saw, R., Quinn, M.,
Shannon, K., Spillane, A., Stretch, J., Scolyer,
R., Thompson, J. (2015). In-transit Melanoma
Metastases: Incidence, Prognosis, and the Role
of Lymphadenectomy. Annals of Surgical
Oncology, 22(2), 475-481. <a
href="http://dx.doi.org/10.1245/s10434-014-410
0-0">[More Information]</a>
Haydu, L., Stollman, L., Scolyer, R., Spillane,
A., Quinn, M., Saw, R., Shannon, K., Stretch, J.,
Bonenkamp, J., Thompson, J. (2016). Minimum
Safe Pathologic Excision Margins for Primary
Cutaneous Melanomas (1-2 mm in Thickness):
Analysis of 2131 Patients Treated at a Single
Center. Annals of Surgical Oncology, 23(4),
1071-1081. <a
href="http://dx.doi.org/10.1245/s10434-015-457
5-3">[More Information]</a>
Busam, K., Vilain, R., Lum, T., Busam, J.,
Hollmann, T., Saw, R., Coit, D., Scolyer, R.,
Wiesner, T. (2016). Primary and Metastatic
Cutaneous Melanomas Express ALK Through
Alternative Transcriptional Initiation. The
American Journal of Surgical Pathology, 40(6),
786-795. <a
href="http://dx.doi.org/10.1097/PAS.000000000
0000611">[More Information]</a>
MacKenzie Ross, A., Haydu, L., Quinn, M.,
Saw, R., Shannon, K., Spillane, A., Stretch, J.,
Scolyer, R., Thompson, J. (2016). The
Association Between Excision Margins and
Local Recurrence in 11,290 Thin (T1) Primary
Cutaneous Melanomas: A Case-Control Study.
Annals of Surgical Oncology, 23(4), 1082-1089.
<a
href="http://dx.doi.org/10.1245/s10434-015-494
2-0">[More Information]</a>
Lyle, M., Haydu, L., Menzies, A., Thompson, J.,
Saw, R., Spillane, A., Kefford, R., Mann, G.,
Cooper, W., Yu, B., Scolyer, R., O'Toole, S.,
Long, G. (2016). The molecular profile of
metastatic melanoma in Australia. Pathology,
48(2), 188-193. <a
href="http://dx.doi.org/10.1016/j.pathol.2015.12.
008">[More Information]</a>
Sanborn, J., Chung, J., Purdom, E., Wang, N.,
Kakavand, H., Wilmott, J., Butler, T.,
Thompson, J., Mann, G., Haydu, L., Saw, R.,
Scolyer, R., et al (2015). Phylogenetic analyses
of melanoma reveal complex patterns of
metastatic dissemination. Proceedings of the
National Academy of Sciences of the United
States of America (PNAS), 112(35),
10995-11000. <a
href="http://dx.doi.org/10.1073/pnas.150807411
2">[More Information]</a>
Read, R., Pasquali, S., Haydu, L., Thompson, J.,
Stretch, J., Saw, R., Quinn, M., Shannon, K.,
Spillane, A. (2015). Quality assurance in
melanoma surgery: The evolving experience at a
large tertiary referral centre. European Journal
of Surgical Oncology, 41(7), 830-836. <a
href="http://dx.doi.org/10.1016/j.ejso.2014.12.00
3">[More Information]</a>
2014
Tan, J., Butow, P., Boyle, F., Saw, R., O’Reilly,
A. (2014). A qualitative assessment of
psychosocial impact, coping and adjustment in
high-risk melanoma patients and caregivers.
Melanoma Research, 24(3), 252-260. <a
href="http://dx.doi.org/10.1097/CMR.00000000
00000059">[More Information]</a>
Keegan, R., Saw, R., De-loyde, K., Young, C.
(2015). Attitudes and risk of withdrawal in
general surgical registrars. New Zealand Medical
Journal, 128(1425), 61-68.
Saw, R., Armstrong, B., Mason, R., Morton, R.,
Shannon, K., Spillane, A., Stretch, J., Thompson,
J. (2014). Adjuvant therapy with high dose
vitamin D following primary treatment of
melanoma at high risk of recurrence: a placebo
controlled randomised phase II trial (ANZMTG
02.09 Mel-D). BMC Cancer, 14, 1-10. <a
href="http://dx.doi.org/10.1186/1471-2407-14-7
80">[More Information]</a>
Winstanley, J., Young, T., Boyle, F., Bergenmar,
M., Bottomley, A., Burmeister, B., Campana, L.,
Garioch, J., King, M., Nikolic, D., Saw, R.,
Thompson, J., et al (2015). Cross-cultural
development of a quality-of-life measure for
patients with melanoma: phase 3 testing of an
EORTC Melanoma Module. Melanoma
Research, 25, 47-58. <a
href="http://dx.doi.org/10.1097/CMR.00000000
00000122">[More Information]</a>
Rizos, H., Menzies, A., Pupo, G., Carlino, M.,
Fung, C., Hyman, J., Haydu, L., Mijatov, B.,
Becker, T., Boyd, S., Howle, J., Saw, R.,
Thompson, J., Kefford, R., Scolyer, R., Long, G.
(2014). BRAF inhibitor resistance mechanisms
in metastatic melanoma: spectrum and clinical
impact. Clinical Cancer Research, 20(7),
1965-1977. <a
href="http://dx.doi.org/10.1158/1078-0432.CCR13-3122">[More Information]</a>
Saw, R., Chakera, A., Stretch, J., Read, R.
(2015). Diverse presentations of acral melanoma.
Long, G., Fung, C., Menzies, A., Pupo, G.,
Carlino, M., Hyman, J., Shahheydari, H., Tembe,
2015
Publications for Robyn Saw
V., Thompson, J., Saw, R., Howle, J., Scolyer,
R., Kefford, R., Rizos, H., et al (2014). Increased
MAPK reactivation in early resistance to
dabrafenib/trametinib combination therapy of
BRAF-mutant metastatic melanoma. Nature
Communications, 5, 1-9. <a
href="http://dx.doi.org/10.1038/ncomms6694">[
More Information]</a>
van der Ploeg, A., Haydu, L., Spillane, A.,
Scolyer, R., Quinn, M., Saw, R., Shannon, K.,
Stretch, J., Thompson, J. (2014). Melanoma
patients with an unknown primary tumor site
have a better outcome than those with a known
primary following therapeutic lymph node
dissection for macroscopic (clinically palpable)
nodal disease. Annals of Surgical Oncology,
21(9), 3108-3116. <a
href="http://dx.doi.org/10.1245/s10434-014-367
9-5">[More Information]</a>
van der Ploeg, A., Haydu, L., Spillane, A.,
Quinn, M., Saw, R., Shannon, K., Stretch, J.,
Uren, R., Scolyer, R., Thompson, J. (2014).
Outcome Following Sentinel Node Biopsy Plus
Wide Local Excision Versus Wide Local
Excision Only for Primary Cutaneous
Melanoma: Analysis of 5840 Patients Treated at
a Single Institution. Annals of Surgery, 260(1),
149-157. <a
href="http://dx.doi.org/10.1097/SLA.000000000
0000500">[More Information]</a>
Huismans, A., Haydu, L., Shannon, K., Quinn,
M., Saw, R., Spillane, A., Stretch, J., Thompson,
J. (2014). Primary Melanoma Location on the
Scalp is an Important Risk Factor for Brain
Metastasis: A Study of 1,687 Patients with
Cutaneous Head and Neck Melanomas. Annals
of Surgical Oncology, 21(12), 3985-3991. <a
href="http://dx.doi.org/10.1245/s10434-014-382
9-9">[More Information]</a>
Lamboo, L., Haydu, L., Scolyer, R., Quinn, M.,
Saw, R., Shannon, K., Spillane, A., Stretch, J.,
Bonenkamp, J., Thompson, J. (2014). The
optimum excision margin and regional node
management for primary cutaneous T3
melanomas (2-4 mm in thickness): A
retrospective study of 1587 patients treated at a
single center. Annals of Surgery, 260(6),
1095-1102. <a
href="http://dx.doi.org/10.1097/SLA.000000000
0000792">[More Information]</a>
Damian, D., Saw, R., Thompson, J. (2014).
Topical Immunotherapy with Diphencyprone for
in Transit and Cutaneously Metastatic
Melanoma. Journal of Surgical Oncology,
109(4), 308-313. <a
href="http://dx.doi.org/10.1002/jso.23506">[Mor
e Information]</a>
2013
Carlino, M., Gowrishankar, K., Saunders, C.,
Pupo, G., Snoyman, S., Zhang, X., Saw, R.,
Becker, T., Kefford, R., Long, G., Rizos, H.
(2013). Antiproliferative Effects of Continued
Mitogen-Activated Protein Kinase Pathway
Inhibition Following Acquired Resistance to
BRAF and/or MEK Inhibition in Melanoma.
Molecular Cancer Therapeutics, 12(7),
1332-1342. <a
href="http://dx.doi.org/10.1158/1535-7163.MCT
-13-0011">[More Information]</a>
Harish, V., Bond, J., Scolyer, R., Haydu, L.,
Saw, R., Quinn, M., Benger, R., Uren, R.,
Stretch, J., Shannon, K., Thompson, J. (2013).
Margins of excision and prognostic factors for
cutaneous eyelid melanomas. Journal of Plastic,
Reconstructive and Aesthetic Surgery, 66(8),
1066-1073. <a
href="http://dx.doi.org/10.1016/j.bjps.2013.04.03
2">[More Information]</a>
Winstanley, J., Saw, R., Boyle, F., Thompson, J.
(2013). The FACT-Melanoma Quality-of-Life
Instrument: comparison of a five-point and
four-point response scale using the Rasch
measurement model. Melanoma Research, 23(1),
61-69. <a
href="http://dx.doi.org/10.1097/CMR.0b013e328
35c7dd9">[More Information]</a>
Pasquali, S., Haydu, L., Scolyer, R., Winstanley,
J., Spillane, A., Quinn, M., Saw, R., Shannon,
K., Stretch, J., Thompson, J. (2013). The
Importance of Adequate Primary Tumor
Excision Margins and Sentinel Node Biopsy in
Achieving Optimal Locoregional Control for
Patients With Thick Primary Melanomas. Annals
of Surgery, 258(1), 152-157. <a
href="http://dx.doi.org/10.1097/SLA.0b013e318
28421e1">[More Information]</a>
2012
Murali, R., Haydu, L., Long, G., Quinn, M.,
Saw, R., Shannon, K., Spillane, A., Stretch, J.,
Kefford, R., Thompson, J., Scolyer, R. (2012).
Clinical and Pathologic Factors Associated with
Distant Metastasis and Survival in Patients with
Thin Primary Cutaneous Melanoma. Annals of
Surgical Oncology, 19(6), 1782-1789. <a
href="http://dx.doi.org/10.1245/s10434-012-226
5-y">[More Information]</a>
Spillane, A., Haydu, L., Lee, N., Uren, R.,
Stretch, J., Shannon, K., Quinn, M., Saw, R.,
McCarthy, W., Thompson, J. (2012). Evaluation
of Incomplete Sentinel Node Biopsy Procedures
and Sentinel Node Positivity Rates as Surgical
Quality-Assurance Parameters in Melanoma
Patients. Annals of Surgical Oncology, 19(12),
3919-3925. <a
href="http://dx.doi.org/10.1245/s10434-012-242
7-y">[More Information]</a>
Publications for Robyn Saw
Murali, R., Haydu, L., Quinn, M., Saw, R.,
Shannon, K., Spillane, A., Stretch, J., Thompson,
J., Scolyer, R. (2012). Sentinel Lymph Node
Biopsy in Patients With Thin Primary Cutaneous
Melanoma. Annals of Surgery, 255(1), 128-133.
<a
href="http://dx.doi.org/10.1097/SLA.0b013e318
2306c72">[More Information]</a>
Pasquali, S., Spillane, A., de Wilt, J., McCaffery,
K., Rossi, C., Quinn, M., Saw, R., Shannon, K.,
Stretch, J., Thompson, J. (2012). Surgeons'
Opinions on Lymphadenectomy in Melanoma
Patients with Positive Sentinel Nodes: A
Worldwide Web-Based Survey. Annals of
Surgical Oncology, 19(13), 4322-4329. <a
href="http://dx.doi.org/10.1245/s10434-012-248
3-3">[More Information]</a>
Martin, R., Shannon, K., Quinn, M., Saw, R.,
Spillane, A., Stretch, J., Colman, M., Gao, K.,
Thompson, J. (2012). The Management of
Cervical Lymph Nodes in Patients with
Cutaneous Melanoma. Annals of Surgical
Oncology, 19(12), 3926-3932. <a
href="http://dx.doi.org/10.1245/s10434-012-237
4-7">[More Information]</a>
Azimi, F., Scolyer, R., Rumcheva, P., Moncrieff,
M., Murali, R., McCarthy, S., Saw, R.,
Thompson, J. (2012). Tumor-Infiltrating
Lymphocyte Grade Is an Independent Predictor
of Sentinel Lymph Node Status and Survival in
Patients With Cutaneous Melanoma. Journal of
Clinical Oncology, 30(21), 2678-2683. <a
href="http://dx.doi.org/10.1200/JCO.2011.37.85
39">[More Information]</a>
2011
Damian, D., Saw, R. (2011). Dramatic regression
of cutaneous, nodal, and visceral melanoma
metastases. Journal Of The American Academy
Of Dermatology, 65(3), 665-666. <a
href="http://dx.doi.org/10.1016/j.jaad.2010.06.00
6">[More Information]</a>
2009
Spillane, A., Cheung, B., Stretch, J., Scolyer, R.,
Shannon, K., Quinn, M., Saw, R., McCarthy, W.,
Thompson, J. (2009). Proposed quality standards
for regional lymph node dissections in patients
with melanoma. Annals of Surgery, 249(3),
473-480. <a
href="http://dx.doi.org/10.1097/SLA.0b013e318
194d38f">[More Information]</a>
Mocellin, S., Thompson, J., Pasquali, S.,
Montesco, M., Pilati, P., Nitti, D., Saw, R.,
Scolyer, R., Stretch, J., Rossi, C. (2009). Sentinel
Node Status Prediction by Four Statistical
Models Results From a Large Bi-Institutional
Series (n=1132). Annals of Surgery, 250(6),
964-969. <a
href="http://dx.doi.org/10.1097/SLA.0b013e318
1b07ffd">[More Information]</a>
2008
Thompson, J., Armstrong, B., Barbour, A.,
Barnetson, R., Beanland, H., Beer, T.,
Brookshank, M., Burmeister, B., Butow, P.,
Clark, K., Conway, R., Damian, D., Frommer,
M., Kefford, R., Lee, S., Mason, R., Mann, G.,
McCarthy, W., Menzies, S., Olver, I., Quinn, M.,
Saw, R., Shaw, H., Stretch, J., Barraclough, B.,
Holt, P., Reeve, T., et al (2008).
Spillane, A., Saw, R., Tucker, M., Byth Wilson,
K., Thompson, J. (2008). Defining lower limb
lymphedema after inguinal or ilio-inguinal
dissection in patients with melanoma using
classification and regression tree analysis. Annals
of Surgery, 248(2), 286-293. <a
href="http://dx.doi.org/10.1097/SLA.0b013e318
17ed7c3">[More Information]</a>
Doubrovsky, A., Scolyer, R., Murali, R.,
McKenzie, P., Watson, G., Lee, C., McLeod, D.,
McCarthy, W., Uren, R., Stretch, J., Saw, R.,
Thompson, J. (2008). Diagnostic Accuracy of
Fine Needle Biopsy for Metastatic Melanoma
and Its Implications for Patient Management.
Annals of Surgical Oncology, 15(1), 323-332. <a
href="http://dx.doi.org/10.1245/s10434-006-934
1-0">[More Information]</a>
Chung, D., Saw, R., Thompson, J. (2008).
Guidelines for imaging in cutaneous melanoma.
Nuclear Medicine Communications, 29(10),
877-879. <a
href="http://dx.doi.org/10.1097/MNM.0b013e32
83043a0c">[More Information]</a>
Chung, D., Saw, R., Thompson, J. (2008).
Imaging in cutaneous melanoma. Nuclear
Medicine Communications, 29(10), 847-876. <a
href="http://dx.doi.org/10.1097/MNM.0b013e32
830439fb">[More Information]</a>
Moncrieff, M., Bowen, F., Thompson, J., Saw,
R., Shannon, K., Spillane, A., Quinn, M.,
Stretch, J. (2008). Keystone Flap Reconstruction
of Primary Melanoma Excision Defects of the
Leg-The End of the Skin Graft. Annals of
Surgical Oncology, 15(10), 2867-2873. <a
href="http://dx.doi.org/10.1245/s10434-008-001
8-8">[More Information]</a>
2007
Murali, R., Doubrovsky, A., Watson, G.,
McKenzie, P., Lee, C., McLeod, D., Uren, R.,
Stretch, J., Saw, R., Thompson, J., Scolyer, R.
(2007). Diagnosis of metastatic melanoma by
fine-needle biopsy: analysis of 2,204 cases.
American Journal of Clinical Pathology, 127(3),
385. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
Publications for Robyn Saw
&list_uids=17276948">[More Information]</a>
Saw, R., Kam, P., Thompson, J. (2007). Isolated
locoregional drug infusion for advanced and
recurrent limb cancer: indications, techniques
and results. Regional Oncotherapies, (pp.
177-191). Greece: Paschalidis Medical
Publications.
2005
van Poll, D., Thompson, J., Colman, M.,
McKinnon, J., Saw, R., Stretch, J., Scolyer, R.,
Uren, R. (2005). A sentinel node biopsy does not
increase the incidence of in-transit metastasis in
patients with primary cutaneous melanoma.
Annals of Surgical Oncology, 12(8), 597-608. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16021534">[More Information]</a>
Thompson, J., Saw, R., Stretch, J. (2005).
Current strategies for the surgical management of
melanoma. Cancer Forum, 29(2), 81-86.
Yee, V., Thompson, J., McKinnon, J., Scolyer,
R., Li, L., McCarthy, W., O'Brien, C., Quinn,
M., Saw, R., Shannon, K., Stretch, J., Uren, R.
(2005). Outcome in 846 cutaneous melanoma
patients from a single center after a negative
sentinel node biopsy. Annals of Surgical
Oncology, 12(6), 429-439. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15886905">[More Information]</a>
2003
Saw, R., Morgan, M., Koorey, D., Painter, D.,
Findlay, M., Stevens, G., Clarke, S., Chapuis, P.,
Solomon, M. (2003). P53, deleted in colorectal
cancer gene, and thymidylate synthase as
predictors of histopathologic response and
survival in low, locally advanced rectal cancer
treated with preoperative adjuvant therapy.
Diseases of the Colon and Rectum, 46(2),
192-202. <a
href="http://dx.doi.org/10.1007/s10350-004-652
4-2">[More Information]</a>
2002
Saw, R., Koorey, D., Painter, D., Gallagher, P.,
Solomon, M. (2002). P53, DCC and thymidylate
synthase as predictors of survival after resection
of hepatic metastases from colorectal cancer.
British Journal of Surgery, 89(11), 1409-1415.